Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome
By M. Pimentel, E. Chow, Henry C. Lin. American Journal of Gastroenterology, 2000
795 citations recorded by the source corpus.
Subfields: Cell Biology, Epidemiology, Gastroenterology
View Paper: https://www.semanticscholar.org/paper/e1a68d1b6f730f06120c1d92905520a39d0c1c91
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cell Biology
In Epidemiology
In Gastroenterology
Citations in the corpus
- Postinfectious irritable bowel syndrome. (2008, background): “lactulose breath testing [45].”
- Efficacy of an Encapsulated Probiotic Bifidobacterium infantis 35624 in Women with Irritable Bowel Syndrome (2006, background): “13 ), coupled with reports of abnormal colonization of the small bowel in some patients”
- Intestinal microbiota in functional bowel disorders: a Rome foundation report (2012, background): “Antibiotics Despite evidence that previous antibiotic use may be related to the development of IBS,(182) 183 and the fact that antibiotic treatment may increase the development of long-term digestive symptoms after bacterial gastroenteritis,(142) poorly absorbable antibiotics might still have therap”
- Normalization of Lactulose Breath Testing Correlates With Symptom Improvement in Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Study (2003, methodology): “We recently reported that 78% of subjects with IBS have a positive lactulose breath test (LBT), suggesting the presence of SIBO (12).”
- Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions (2010, background): “Some studies have suggested that small intestinal bacterial overgrowth (SIBO), for example, is frequent among patients with IBS”